Share-based Payment Arrangement, Expense of Avidity Biosciences, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avidity Biosciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $43,419,000, a 207% increase year-over-year.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $97,838,000, a 90% increase year-over-year.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $97,838,000, a 90% increase from 2024.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $51,363,000, a 34% increase from 2023.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $38,222,000, a 41% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Avidity Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $97,838,000 $43,419,000 +$29,266,000 +207% 01 Oct 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 $68,572,000 $19,024,000 +$4,932,000 +35% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $63,640,000 $17,659,000 +$4,847,000 +38% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $58,793,000 $17,736,000 +$7,430,000 +72% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $51,363,000 $14,153,000 +$4,308,000 +44% 01 Oct 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 $47,055,000 $14,092,000 +$4,272,000 +44% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $42,783,000 $12,812,000 +$3,359,000 +36% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $39,424,000 $10,306,000 +$1,202,000 +13% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $38,222,000 $9,845,000 +$2,538,000 +35% 01 Oct 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
Q3 2023 $35,684,000 $9,820,000 +$2,734,000 +39% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $32,950,000 $9,453,000 +$2,945,000 +45% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $30,005,000 $9,104,000 +$2,866,000 +46% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $27,139,000 $7,307,000 +$2,791,000 +62% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $24,348,000 $7,086,000 +$2,536,000 +56% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $21,812,000 $6,508,000 +$2,219,000 +52% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $19,593,000 $6,238,000 +$2,537,000 +69% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $17,056,000 $4,516,000 +$2,638,000 +140% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $14,418,000 $4,550,000 +$3,254,000 +251% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $11,164,000 $4,289,000 +$3,602,000 +524% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $7,562,000 $3,701,000 +$3,252,000 +724% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $4,310,000 $1,878,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $1,296,000 +$1,274,000 +5791% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $687,000 +$671,000 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $449,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q3 2019 $22,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $16,000* 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2

Avidity Biosciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $97,838,000 +$46,475,000 +90% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $51,363,000 +$13,141,000 +34% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $38,222,000 +$11,083,000 +41% 01 Jan 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
2022 $27,139,000 +$10,083,000 +59% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $17,056,000 +$12,746,000 +296% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $4,310,000 +$3,904,000 +962% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $406,000 +$346,000 +577% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $60,000 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.